JINGHUA PHARM released its performance for the first three quarters, with a net profit attributable to the parent company of 176 million yuan, a year-on-year increase of 7.39%
According to the Zhitong Finance APP, JINGHUA PHARM released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 1.092 billion yuan, a year-on-year increase of 4.51%. The net profit attributable to shareholders of the listed company was 176 million yuan, a year-on-year increase of 7.39%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 170 million yuan, a year-on-year increase of 9.17%
According to the Zhitong Finance APP, JINGHUA PHARM (002349.SZ) released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 1.092 billion yuan, a year-on-year increase of 4.51%. The net profit attributable to shareholders of the listed company was 176 million yuan, a year-on-year increase of 7.39%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 170 million yuan, a year-on-year increase of 9.17%
